Sodium Nitroprusside
NDC Package 72485-305-01

View Billable Units, 11-Digit Conversion Format, and RxNorm mappings
Table of Contents
    1. Package Information
    2. Frequently Asked Questions

Package Information

This product is EXCLUDED from the official NDC directory because the listing data was inactivated by the FDA.

Sodium Nitroprusside is injection is indicated for the immediate reduction of blood pressure of adult and pediatric patients in hypertensive crises. Marketed by Armas Pharmaceuticals Inc., this product is identified by NDC 72485-305 and is authorized under FDA application ANDA209352.

Identification & Billing

NDC Package Code
72485-305-01
Package Description
1 VIAL, SINGLE-DOSE in 1 CARTON / 2 mL in 1 VIAL, SINGLE-DOSE
Product Code
72485-305
11-Digit Billing Format
72485030501
Billing Unit
ML - Billing unit of "milliliter" is used when a product is measured by its liquid volume.
RxNorm Crosswalk

Clinical Specifications

Proprietary Name
Sodium Nitroprusside
Dosage Form
-
Usage Information
Sodium nitroprusside injection is indicated for the immediate reduction of blood pressure of adult and pediatric patients in hypertensive crises. Concomitant longer-acting antihypertensive medication should be administered so that the duration of treatment with sodium nitroprusside can be minimized.Sodium nitroprusside injection is also indicated for producing controlled hypotension in order to reduce bleeding during surgery.Sodium nitroprusside injection is also indicated for the treatment of acute congestive heart failure.

Regulatory & Marketing

Labeler Name
Armas Pharmaceuticals Inc.
FDA Application #
ANDA209352
Marketing Category
ANDA - A product marketed under an approved Abbreviated New Drug Application.
Start Marketing Date
09-15-2021
Listing Expiration
12-31-2024
Exclude Flag
I
Sample Package
No

Hierarchy Structure

Code Lineage

The NDC Directory contains ONLY information on final marketed drugs submitted to FDA electronically by labelers. A labeler might be a manufacturer, re-packager or re-labeler. The product information included in the NDC directory does not indicate that FDA has verified the information provided by the product labeler. Assigned NDC numbers are not in any way an indication of FDA approval of the product.

* Please review the full disclaimer at the bottom of this page.

Frequently Asked Questions

What is the distribution configuration for this product package?

The code 72485-305-01 identifies a specific commercial package of 1 vial, single-dose in 1 carton / 2 ml in 1 vial, single-dose of Sodium Nitroprusside, labeled by Armas Pharmaceuticals Inc.. This is formulated for use and contains as the active substance.

Is this product currently listed with the FDA?

This product code is currently listed as inactive or excluded from the primary directory. It was introduced to the market by Armas Pharmaceuticals Inc. on September 15, 2021. The current certification is valid through December 31, 2024.

How is this Armas Pharmaceuticals Inc. product billed for insurance claims?

For medical billing and reimbursement, this package follows the 11-digit CMS format: 72485030501. Quantities are measured in per "ml or milliliter", products billed per milliliter are usually products measured by liquid volume.. The table below illustrates the segment conversion from the 10-digit labeler code to the 11-digit provider format.

11-Digit Code Conversion

Billing payers usually require a 5-4-2 segment configuration. Below is the conversion from the 10-digit package format to the 11-digit billing format:

10-Digit Format (5-3-2)
72485-305-01
11-Digit CMS (5-4-2)
72485-0305-01

Note: The zero is added to the Product segment to maintain the 5-4-2 structure.